Very Low-debt Balance SheetNegligible debt materially reduces financial risk and preserves strategic flexibility. Over the next 2–6 months a low-leverage profile supports funding for R&D, product investment or opportunistic M&A, cushions operational shocks, and keeps interest burden minimal, strengthening durability.

Revenue Rebound In 2025A clear top-line recovery in 2025 suggests demand resilience and the potential for restoring growth momentum. If sustained, this improves operating leverage, helps reverse margin pressure and aids cash conversion, indicating a path toward more durable profitability over coming quarters.

Exposure To Medical Equipment SectorOperating in medical equipment and services links the company to structurally stable healthcare demand. This end-market tends to be less cyclical than consumer sectors, supporting steadier long-term revenue streams and recurring replacement/service opportunities important for durable business fundamentals.

Bears Say

Weak Recent Cash GenerationNegative operating and free cash flow in the last two years erodes the company's ability to self-fund capex, R&D, or dividends without drawing on reserves or raising external capital. Persistent weak cash conversion undermines long-term reinvestment and financial resilience.

Thin And Compressed MarginsVery slim net and operating margins leave little buffer against cost inflation, pricing pressure or demand softness. Margin compression limits cash flow upside from revenue gains and makes profitability more sensitive to small adverse changes in costs or volumes over the medium term.

Declining Returns On EquityA marked drop in ROE signals the firm is generating much lower profitability from its capital base. Even with low leverage, weak returns limit shareholder value creation and indicate operational or pricing challenges that management must address to restore durable profit generation.

7681 FAQ

What was LEOCLAN Co. Ltd.’s price range in the past 12 months?

LEOCLAN Co. Ltd. lowest stock price was ¥798.00 and its highest was ¥1319.00 in the past 12 months.

What is LEOCLAN Co. Ltd.’s market cap?

LEOCLAN Co. Ltd.’s market cap is ¥5.32B.

When is LEOCLAN Co. Ltd.’s upcoming earnings report date?

LEOCLAN Co. Ltd.’s upcoming earnings report date is May 14, 2026 which is in 62 days.

How were LEOCLAN Co. Ltd.’s earnings last quarter?

LEOCLAN Co. Ltd. released its earnings results on Feb 13, 2026. The company reported -¥13.46 earnings per share for the quarter, missing the consensus estimate of N/A by -¥13.46.

Is LEOCLAN Co. Ltd. overvalued?

According to Wall Street analysts LEOCLAN Co. Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does LEOCLAN Co. Ltd. pay dividends?

LEOCLAN Co. Ltd. pays a Annually dividend of ¥17 which represents an annual dividend yield of 1.67%. See more information on LEOCLAN Co. Ltd. dividends here

What is LEOCLAN Co. Ltd.’s EPS estimate?

LEOCLAN Co. Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does LEOCLAN Co. Ltd. have?

LEOCLAN Co. Ltd. has 5,922,000 shares outstanding.

What happened to LEOCLAN Co. Ltd.’s price movement after its last earnings report?

LEOCLAN Co. Ltd. reported an EPS of -¥13.46 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -2.857%.

Which hedge fund is a major shareholder of LEOCLAN Co. Ltd.?

Currently, no hedge funds are holding shares in JP:7681

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

LEOCLAN Co. Ltd.

LEOCLAN Co.,Ltd. operates as a medical equipment trading company that meets various medical care, welfare, and health needs. It operates through three segments: Medical Total Solutions Business, Remote Image Diagnosis Service Business, and School Lunch Business. The Medical Total Solutions Business segment provides incidental maintenance services; and interior decoration construction and installation works for medical institutions, preventive/health checkup facilities, nursing care/welfare facilities, etc. based on consulting services such as selection of medical equipment, as well as sells medical equipment and medical information systems. The Remote Image Diagnosis Service Business segment offers services in which diagnostic radiology specialists remotely diagnose image data taken by MRI, CT, etc., and provides information. The School Lunch Business segment provides school lunch services, including regular meals, medical meals, and other meals to nursing care and welfare facilities. LEOCLAN Co.,Ltd. was incorporated in 2001 and is headquartered in Settsu, Japan.